Full story: https://grafa.com/en/news/united-states/netflix-q3-2026-revenue-12-87-billion-ad-guidance Netflix reported third-quarter 2026 revenue of $12.87 billion, up 11.8% year over year, while net income increased approximately 44% to $3.66 billion. Operating income rose 37% to $4.46 billion, with operating margin expanding to 34.6% from 28.2%, exceeding management's forecast partly because of expense timing. Netflix expects annual revenue of $51.1 billion but reduced its advertising revenue forecast to $2.7 billion and free cash flow outlook to approximately $12 billion. Netflix (NASDAQ:NFLX) reported third-quarter 2026 revenue of $12.87 billion, up 11.8% year over year, supported by subscription pricing, membership growth and advertising. Operating income increased 37% to $4.46 billio

Full story: https://grafa.com/en/news/united-states/ge-aerospace-q3-2026-revenue-14-billion-earnings-guidance GE Aerospace reported third-quarter 2026 adjusted earnings of $2.25 per share, up 36% year over year and exceeding analysts' estimates of approximately $2–$2.01. GAAP revenue rose 16% to $14.12 billion, while adjusted revenue increased 18% to approximately $13.29 billion and total orders surged 49% to $19 billion. GE Aerospace increased its full-year adjusted EPS outlook to $8–$8.10, operating profit guidance to $10.9 billion–$11 billion and free cash flow forecast to $9.1 billion–$9.4 billion. GE Aerospace (NYSE:GE) reported third-quarter 2026 GAAP revenue of $14.12 billion, up 16% year over year, as demand for aircraft engines and maintenance remained strong. Adjusted earnings in

Full story: https://grafa.com/en/news/united-states/spacex-q3-2026-revenue-14-58-billion-earnings-beat SpaceX (NASDAQ:SPCX) generated $14.58 billion in third-quarter 2026 revenue, exceeding Bloomberg's consensus estimate of $12.7 billion by approximately 14.8%. Adjusted EBITDA reached $8.81 billion, above the $6.59 billion forecast, while capital expenditures totaled $19.59 billion, largely reflecting AI computing infrastructure investments. SpaceX shares were reported at $147.79 following the earnings announcement, while investors assessed the company's expanding AI business, Starlink operations and substantial capital spending. SpaceX (NASDAQ:SPCX) generated third-quarter 2026 revenue of $14.58 billion, exceeding analysts' $12.7 billion forecast as its AI and connectivity businesses expa

Full story: https://grafa.com/en/news/united-states/halliburton-q3-2026-revenue-5-7-billion-earnings Halliburton reported third-quarter 2026 revenue of $5.7 billion and adjusted earnings of $0.60 per share, exceeding analysts' estimates of $0.58 per share and $5.58 billion in revenue. GAAP net income declined sequentially to $417 million, while adjusted net income increased to $501 million; operating cash flow reached $368 million and free cash flow totaled $156 million. Halliburton expects mid-single-digit revenue growth and operating margins of approximately 15% in 2027, supported by international oilfield activity and expected demand for energy infrastructure restoration. Halliburton (NYSE:HAL) reported third-quarter 2026 revenue of $5.7 billion, exceeding analyst expectations, while ad

Full story: https://grafa.com/en/news/united-states/general-motors-q3-2026-earnings-20-billion-buyback General Motors reported third-quarter 2026 revenue of $50 billion, while net income attributable to shareholders increased to $3.335 billion, from $1.327 billion a year earlier. Adjusted earnings before interest and taxes rose 21.6% to $4.106 billion, supported by demand for high-margin pickup trucks and SUVs, although international operations and GM Financial recorded weaker earnings. GM increased its 2026 adjusted automotive free cash flow forecast to $11.5 billion–$12.5 billion, authorized a new $20 billion multi-year share repurchase program and declared a quarterly dividend of $0.18 per share. General Motors (NYSE:GM) reported third-quarter 2026 revenue of $50 billion, while net inco

Full story: https://grafa.com/en/news/australia/woodside-energy-lifts-q3-revenue-to-us-4-28b Woodside Energy generated quarterly operating revenue of US$4.281 billion, driven by higher realised LNG prices and stronger production volumes. The company's quarterly production rose 12% to 46.2 million barrels of oil equivalent, sending its stock to $33.70. Woodside adjusted its full-year output guidance to 174–181 MMboe while pushing major projects towards key completion milestones. Woodside Energy (ASX:WDS) posted a 2% revenue increase to US$4.281 billion for Q3 2026, boosted by a 27% jump in average realised LNG prices. The result shows a strong operational rebound from Q2 2026, when extensive plant maintenance and turnaround activities temporarily restricted Pluto LNG output. Woodside CEO Li

Full story: https://grafa.com/en/news/australia/telix-pharmaceuticals-revenue-rises-19-to-us-245m Telix Pharmaceuticals reported group revenue of US$245 million for the third quarter of 2026, marking a 19% increase from the prior corresponding period. Strong commercial demand for precision medicine imaging products drove quarterly revenue higher. The company reaffirmed its full-year 2026 revenue guidance to exceed US$1 billion. Telix Pharmaceuticals (ASX:TLX) generated US$245 million in group revenue during the third quarter of 2026, up 19% in the prior-year period. The quarterly revenue growth was primarily led by a 30% increase in precision medicine revenue to US$201 million, which offset a 6% decline in manufacturing solutions revenue. The company stated that the transaction with Isotop

Full story: https://grafa.com/en/news/australia/westgold-resources-builds-cash-reserve-to-1-04b Westgold Resources recorded first-quarter FY27 gold production of 98.4 thousand ounces with an all-in sustaining cost of $2,912 per ounce. Cash, bullion, and liquid investments increased by $101 million to $1.04 billion while maintaining zero debt. The business remains on track to achieve full-year FY27 guidance of 385 to 425 thousand ounces. Westgold Resources (ASX:WGX) reported first-quarter FY27 gold production of 98.4 thousand ounces while expanding its underlying cash, bullion, and liquid investment reserves by $101 million to reach $1.04 billion. This performance follows gold production of 98.9 thousand ounces in the prior quarter, during which all-in sustaining costs rose from $2,802 per

Full story: https://grafa.com/en/news/australia/northern-star-reports-higher-costs-and-lower-output Northern Star Resources reported a lower gold output of nearly 364,000 ounces alongside a 20% cost increase to $3,217 per ounce for the September quarter. The operational update coincides with an uninvited takeover approach from Gold Fields, which previously valued the Australian miner at nearly $39 billion. Northern Star stated that the cost increases stemmed from integrating its new $1.8 billion mill at the Kalgoorlie Consolidated Gold Mines operations. Northern Star Resources (ASX:NST) posted a quarterly gold production drop of roughly 19% to nearly 364,000 ounces while its all-in sustaining costs rose 20% to $3,217 per ounce. The latest quarterly figures followed an uninvited takeover pr

Full story: https://grafa.com/en/news/australia/atlas-arteria-proportional-toll-revenue-falls-0-4 Proportional toll revenue dropped 0.4% in Q3 2026, excluding foreign exchange movements. Reported toll revenue fell 8.9% due to adverse foreign exchange rate fluctuations. Proposed French tax law changes could add €210 million in costs for APRR. Atlas Arteria (ASX:ALX) reported a 0.4% drop in proportional toll revenue excluding foreign exchange movements for Q3 2026. The revenue change compares to the prior corresponding period, while reported proportional toll revenue declined 8.9% due to foreign exchange movements. Higher fuel prices in France negatively impacted light vehicle traffic, contrasting with positive traffic growth across US and German assets. The French government proposed a draf

Full story: https://grafa.com/en/news/australia/sigma-healthcare-posts-double-digit-sales-growth Sigma Healthcare reported double-digit sales growth across its Australian and international Chemist Warehouse store network. Following the update, the Sigma Healthcare share price dropped 3.18% to $2.76. The company plans to expand its network towards 1,000 global stores and leverage oral GLP-1 products to drive long-term sales. Sigma Healthcare (ASX:SIG) delivered strong sales growth across its Chemist Warehouse store network in Australia and international markets. Australian Chemist Warehouse stores recorded a 12.1% sales increase from July 1 to Oct. 16, while international sales jumped 30.2% in the three months to Sept. 30. "Consistent with our FY26 results presentation, some discretionary c

Full story: https://grafa.com/en/news/australia/nextdc-cuts-fy27-revenue-guidance-on-melbourne-delays NEXTDC lowered its FY27 net revenue guidance to $475–$500 million due to electricity supply delays at its M3 Melbourne data centre. Revised FY27 underlying EBITDA fell to $245-$265 million, while capital expenditure guidance was cut by $750 million. Electricity network operator Jemena suspended grid upgrade works at M3 following opposition from local community stakeholders. NEXTDC (ASX:NXT) reduced its FY27 net revenue forecast to $475–$500 million after electricity connection delays halted expansion plans at its M3 Melbourne data facility. The revised figure compares with prior full-year net revenue guidance of $615–$640 million issued by the company in August. Network provider Jemena Ele

Full story: https://grafa.com/en/news/united-states/mako-mining-q3-2026-12743-ounces-gold-production Mako Mining recovered 12,743 ounces of gold in Q3 2026 and sold 11,581 ounces, generating approximately US$50 million in revenue. Cash, securities and trade receivables totalled US$119.3 million at September 30, compared with approximately US$112 million reported in Q2. Mako expects Moss Mine throughput to exceed 12,000 short tons daily by Q3 2027 and anticipates first gold production at Mt. Hamilton in December 2027. Mako Mining (NASDAQ:MAKO) recovered 12,743 ounces of gold in Q3 2026, generating approximately US$50 million in revenue from 11,581 ounces sold. Gold sales declined from 14,610 ounces in Q2, while cash, securities and trade receivables increased to US$119.3 million from approx

Full story: https://grafa.com/en/news/united-states/peoples-bancorp-q3-2026-earnings-5-7-million Peoples Bancorp of North Carolina reported Q3 2026 net earnings of $5.7 million, compared with $3.7 million a year earlier, while diluted earnings per share increased to $1.05 from $0.67. Net interest income rose to $16.7 million from $15.1 million, while net interest margin widened to 3.85% from 3.58%. Loans reached $1.30 billion and deposits totaled $1.57 billion at September 30, although the equity-to-assets ratio declined to 8.95%. Peoples Bancorp of North Carolina (NASDAQ:PEBK) reported third-quarter 2026 net earnings of $5.7 million, up approximately 54% from $3.7 million a year earlier. Diluted earnings per share increased to $1.05 from $0.67, while net interest income rose approximately

Full story: https://grafa.com/en/news/united-states/alpha-tau-fda-regain-trial-expansion-20-patients Alpha Tau Medical received FDA approval to expand its U.S. REGAIN trial of Alpha DaRT from 10 to up to 20 patients across three academic cancer centers. The updated protocol includes IDH-mutant grade 4 tumors, progression-free survival measurements and regular quality-of-life assessments. Alpha Tau will present additional REGAIN data on November 13, 2026, and believes the expanded study could support future regulatory submission requirements. Alpha Tau Medical (NASDAQ:DRTS) received FDA authorization to expand its REGAIN brain cancer trial from 10 to 20 patients across three U.S. centers. The expansion follows June 2026 FDA clearance to complete the original enrollment, after interim findin

Full story: https://grafa.com/en/news/united-states/eos-energy-q3-2026-83-million-revenue-outlook Eos Energy Enterprises expects preliminary Q3 2026 revenue of US$82–US$83 million, representing 19%–21% sequential growth and 169%–172% year-over-year growth. Expected GAAP gross margin improved to negative 55%–53%, while total cash, including restricted cash, declined to approximately US$344 million. Eos expects full-year revenue in the lower half of its US$300–US$350 million guidance range and plans to introduce 24-hour operations at Thorn Hill in Q4 2026. Eos Energy Enterprises (NASDAQ:EOSE) expects preliminary third-quarter 2026 revenue of US$82–US$83 million, representing 169%–172% growth from the prior year. Revenue increased an estimated 19%–21% sequentially, while the expected GAAP gro

Full story: https://grafa.com/en/news/united-states/trigemx-bio-tcgx-246-million-spac-merger TriGemX Bio and TCGX Acquisition Corp. signed a definitive business combination agreement that would take the migraine drug developer public on Nasdaq under the proposed ticker TGEM. The transaction is expected to generate approximately $246 million in gross proceeds, including a $160 million private investment in public equity (PIPE) and approximately $86 million held in the SPAC's trust account. TriGemX expects the proceeds to support Phase 3 trials of elismetrep, additional migraine prevention research and preparations for a potential U.S. commercial launch. TCGX Acquisition Corp. (NASDAQ:TCGX) agreed to merge with TriGemX Bio in a transaction expected to generate approximately $246 million in g

Full story: https://grafa.com/en/news/united-states/johnson-johnson-tremfya-35-percent-crohns-fistula-remission Johnson & Johnson reported that TREMFYA achieved a 35% combined fistula remission rate at Week 48 in its Phase 3 FUZION trial, up from 28% at Week 24. At Week 24, remission rates were 28% and 27% across the two TREMFYA maintenance doses, compared with 10% for placebo. The findings add one-year evidence for TREMFYA in perianal fistulizing Crohn's disease, with more than 90% of randomized patients completing treatment through Week 48. Johnson & Johnson (NYSE:JNJ) reported 35% combined fistula remission at Week 48 with TREMFYA in its Phase 3 FUZION Crohn's disease trial. Remission increased from 28% at Week 24 for the 100 mg eight-week regimen, while the 200 mg four-week reg

Full story: https://grafa.com/en/news/united-states/blackstone-8-7-billion-energy-transition-fund-close Blackstone announced the final close of Blackstone Energy Transition Partners V at US$8.7 billion, more than 50% larger than its predecessor fund. Blackstone reported a 34% net internal rate of return for its energy transition strategy since 1997, measured as of June 30, 2026. The fund is targeting power generation, electricity transmission, energy infrastructure and efficiency businesses, with six initial platform investments and acquisitions already announced. Blackstone (NYSE:BX) closed its fifth energy transition private equity fund at US$8.7 billion, exceeding its predecessor's US$5.6 billion fundraising total by approximately 55%. The oversubscribed fund reached its fundraising cap

Full story: https://grafa.com/en/news/united-states/cleveland-cliffs-q3-2026-612-million-adjusted-ebitda Cleveland-Cliffs reported $612 million in Q3 2026 adjusted EBITDA, exceeding its previous US$575 million guidance by $37 million. Revenue increased to $5.6 billion from $5.2 billion in Q2, while the company returned to a $165 million net profit from a $134 million loss. Cleveland-Cliffs expects 2027 adjusted EBITDA to exceed $4 billion, while planning to idle Stelco galvanizing lines and reduce debt. Cleveland-Cliffs (NYSE:CLF) reported $612 million in third-quarter adjusted EBITDA, exceeding its $575 million guidance, as revenue reached $5.6 billion. Revenue rose from $5.2 billion in Q2, while net income improved to $165 million from a $134 million loss. Steel shipments reached 4.2 mil